VTRS
What one share of Viatris holds
Pharmaceutical Preparations
Viatris is a global healthcare company whose breadth and scale we believe make it uniquely positioned to address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, Viatris supplies high-quality medicines to approximately 1 billion patients around the world each year.
Viatris’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $12.63 |
|---|---|
| Profit | −$0.35 |
| Capex (buildings and equipment) | $0.32 |
| Free cash flow | $1.67 |
| Dividends | $0.48 |
| Cash and investments | $0.77 |
| Debt | $11.62 |
| Book value | $12.42 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2018 | $22.14 | $0.68 | $0.49 | $4.05 | — | $23.65 |
| 2019 | $22.27 | $0.03 | $0.41 | $3.08 | — | — |
| 2020 | $19.87 | −$1.11 | $0.40 | $1.64 | — | — |
| 2021 | $14.80 | −$1.05 | $0.38 | $2.12 | $0.33 | $16.94 |
| 2022 | $13.36 | $1.71 | $0.33 | $2.13 | $0.48 | $17.61 |
| 2023 | $12.78 | $0.05 | $0.31 | $2.09 | $0.48 | $17.23 |
| 2024 | $12.32 | −$0.53 | $0.27 | $1.65 | $0.48 | $15.61 |
| 2025 | $12.21 | −$3.00 | $0.32 | $1.65 | $0.48 | $12.78 |